Concepedia

Helen Clare Dearden

HC

4

Publications

484

Citations

4

H-Index

2017

Active since

Affiliations

The University of Sydney(Current)

Melanoma Institute Australia

Royal North Shore Hospital

The University of Queensland

Westmead Hospital

Helen Clare Dearden is an author at The University of Sydney specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2017–2023

4

Publications

4

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma

Megan H. Pollack, Helen Clare Dearden, K. Rapazzo et al. · Annals of Oncology · 2017 · 381 citations · Full text

, , +9

Combined ipilimumab and nivolumab first‐line and after BRAF‐targeted therapy in advanced melanoma

Robert M. Mason, Helen Clare Dearden, Bella Nguyen et al. · Pigment Cell & Melanoma Research · 2019 · 62 citations · Full text

Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy

Helen Clare Dearden, Lewis Au, Daniel Wang et al. · European Journal of Cancer · 2021 · 29 citations

, , +7

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia

Samuel Cass, Joshua W.D. Tobin, Yongwoo David Seo et al. · Annals of Oncology · 2023 · 12 citations · Full text

Rows per page

1–4 of 4